43 results
8-K/A
EX-99.2
385hv6yp88nqmrzzqqy
5 Jan 24
Independent Auditors’ Report
4:01pm
8-K/A
EX-99.1
ahdq89d5isuc
5 Jan 24
Independent Auditors’ Report
4:01pm
8-K
EX-2.1
ohg4c4oo uc0rdp
24 Jul 23
Entry into a Material Definitive Agreement
7:16am
PRE 14A
425w6a4ihh
4 Apr 23
Preliminary proxy
4:33pm
8-K
EX-3.2
yjm7r5nmlxn
1 Aug 22
Quince Therapeutics Details Strategic Growth Plan with Launch of New Corporate Name
9:17am
8-K
EX-2.1
wcq8f0m8phqk
12 May 22
Entry into a Material Definitive Agreement
5:12pm
POS AM
daz mfzvk88
4 Mar 22
Prospectus update (post-effective amendment)
4:04pm